These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16246954)

  • 1. Letter regarding article by Patti et al, "Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: results from the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) study".
    Tricoci P; Harrington RA; Valgimigli M
    Circulation; 2005 Oct; 112(17):e282; author reply e283. PubMed ID: 16246954
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter regarding article by Patti et al, "Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: results from the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) study".
    Palabrica TM; Burton PB
    Circulation; 2005 Oct; 112(17):e282-3; author reply e283. PubMed ID: 16250083
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiplatelet effect of 600- and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an analysis of the ARMYDA-6 MI (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Myocardial Infarction) Study.
    Mangiacapra F; Patti G; Barbato E; Orlic D; Peace AJ; D'Ambrosio A; Ostojic M; Wijns W; Di Sciascio G
    Int J Cardiol; 2012 Oct; 160(3):213-4. PubMed ID: 22727961
    [No Abstract]   [Full Text] [Related]  

  • 4. Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: results from the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) study.
    Patti G; Colonna G; Pasceri V; Pepe LL; Montinaro A; Di Sciascio G
    Circulation; 2005 Apr; 111(16):2099-106. PubMed ID: 15750189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiplatelet therapy with clopidogrel or ticlopidine reduces intimal hyperplasia in an animal model of experimental arterial injury.
    Kloppenburg G
    Anadolu Kardiyol Derg; 2010 Feb; 10(1):17. PubMed ID: 20149999
    [No Abstract]   [Full Text] [Related]  

  • 6. Outcome comparison of 600- and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: results from the ARMYDA-6 MI (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Myocardial Infarction) randomized study.
    Patti G; Bárczi G; Orlic D; Mangiacapra F; Colonna G; Pasceri V; Barbato E; Merkely B; Edes I; Ostojic M; Wijns W; Di Sciascio G
    J Am Coll Cardiol; 2011 Oct; 58(15):1592-9. PubMed ID: 21958886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clopidogrel reloading in patients undergoing percutaneous coronary intervention on chronic clopidogrel therapy: results of the ARMYDA-4 RELOAD (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) randomized trial.
    Di Sciascio G; Patti G; Pasceri V; Colonna G; Mangiacapra F; Montinaro A;
    Eur Heart J; 2010 Jun; 31(11):1337-43. PubMed ID: 20363764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of in-laboratory high-dose clopidogrel loading versus routine pre-load in patients undergoing percutaneous coronary intervention: results of the ARMYDA-5 PRELOAD (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) randomized trial.
    Di Sciascio G; Patti G; Pasceri V; Gatto L; Colonna G; Montinaro A;
    J Am Coll Cardiol; 2010 Aug; 56(7):550-7. PubMed ID: 20688209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abciximab in patients with acute ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention after clopidogrel loading: a randomized double-blind trial.
    Mehilli J; Kastrati A; Schulz S; Früngel S; Nekolla SG; Moshage W; Dotzer F; Huber K; Pache J; Dirschinger J; Seyfarth M; Martinoff S; Schwaiger M; Schömig A;
    Circulation; 2009 Apr; 119(14):1933-40. PubMed ID: 19332467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment with different loading doses of clopidogrel influences P-selectin levels in patients undergoing percutaneous coronary intervention: results from the ARMYDA-2 (antiplatelet therapy for reduction of myocardial damage during angioplasty) SELECT substudy.
    Patti G; Chello M; Pasceri V; Colonna D; Colonna G; Pepe LL; Montinaro A; Covino E; Di Sciascio G
    J Cardiovasc Med (Hagerstown); 2011 Mar; 12(3):151-6. PubMed ID: 21085001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial.
    Montalescot G; Wiviott SD; Braunwald E; Murphy SA; Gibson CM; McCabe CH; Antman EM;
    Lancet; 2009 Feb; 373(9665):723-31. PubMed ID: 19249633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of clopidogrel in the reduction of myocardial damage during percutaneous coronary intervention.
    Dasgupta A; Mukherjee D
    Vasc Health Risk Manag; 2009; 5(1):275-86. PubMed ID: 19436675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized trial comparing clopidogrel versus ticlopidine therapy in patients undergoing infarct artery stenting for acute myocardial infarction with abciximab as adjunctive therapy.
    Parodi G; Sciagrà R; Migliorini A; Memisha G; Moschi G; Valenti R; Pupi A; Antoniucci D
    Am Heart J; 2005 Aug; 150(2):220. PubMed ID: 16086921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of clopidogrel reloading in patients with acute coronary syndrome undergoing percutaneous coronary intervention during chronic clopidogrel therapy (from the Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty [ARMYDA-8 RELOAD-ACS] trial).
    Patti G; Pasceri V; Mangiacapra F; Colonna G; Vizzi V; Ricottini E; Montinaro A; D'Ambrosio A; Wijns W; Barbato E; Di Sciascio G;
    Am J Cardiol; 2013 Jul; 112(2):162-8. PubMed ID: 23601577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention of periprocedural myocardial damage in patients undergoing percutaneous coronary intervention].
    Patti G; Pasceri V; Nusca A; Di Sciascio G
    Ital Heart J Suppl; 2005 Sep; 6(9):553-60. PubMed ID: 16281714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High residual platelet reactivity after clopidogrel: extent of coronary atherosclerosis and periprocedural myocardial infarction in patients with stable angina undergoing percutaneous coronary intervention.
    Mangiacapra F; De Bruyne B; Muller O; Trana C; Ntalianis A; Bartunek J; Heyndrickx G; Di Sciascio G; Wijns W; Barbato E
    JACC Cardiovasc Interv; 2010 Jan; 3(1):35-40. PubMed ID: 20129566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clopidogrel use in coronary heart disease and percutaneous coronary intervention.
    Atiemo AD; Williams MS
    J Investig Med; 2008 Apr; 56(4):689-700. PubMed ID: 18382265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High on clopidogrel treatment platelet reactivity is frequent in acute and rare in elective stenting and can be functionally overcome by switch of therapy.
    Leé S; Vargová K; Hizoh I; Horváth Z; Gulácsi-Bárdos P; Sztupinszki Z; Apró A; Kovács A; Préda I; Tóth-Zsámboki E; Kiss RG
    Thromb Res; 2014 Feb; 133(2):257-64. PubMed ID: 24359966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between ticlopidine and clopidogrel in patients undergoing primary stenting in acute myocardial infarction: results from the CADILLAC trial.
    Lansky AJ; Tsuchiya Y; Brener M; Mehran R; Cristea E; Pietras C; Grines CL; Cox DA; Garcia E; Tcheng JE; Guagliumi G; Stuckey T; Turco M; Carroll JD; Rutherford BD; Leon MB; Moses J; Stone GW
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):917-24. PubMed ID: 19016469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Letter by Serebruany regarding article, "Cost-effectiveness of prasugrel versus clopidogrel in patients with acute coronary syndromes and planned percutaneous coronary intervention: results from the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in Myocardial Infarction TRITON-TIMI 38".
    Serebruany VL
    Circulation; 2010 Aug; 122(8):e436; author reply e437. PubMed ID: 20733108
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.